![学納金サイト [在学生・保護者専用]](/assets/images/BlkFeatured_item_tuition.jpg)
School of Medicine教員紹介：柴山 隆宏
| 氏名 |
柴山 隆宏
シバヤマ タカヒロ |
|---|---|
| 職位 | 助教 |
| 所属教室 | |
| 専門分野 | 病理診断 |
| 研究テーマ | 診断病理 |
| 略歴 | 2012 年 筑波大学卒業 |
| 所有する学位 | 学士（医学） |
| 指導医・専門医・認定医、その他の資格等 | 病理専門医・指導医 分子病理専門医 細胞診専門医 |
| 論文・著書等を含む主要研究業績 |
1. Shibayama T, et al. Combination immunohistochemistry for CK5/6, p63, GATA6, and HNF4a predicts clinical outcome in treatment-naïve pancreatic ductal adenocarcinoma. Sci Rep. 2024;14(1):15598. 2. Shibayama T, et al. Gastric mesenchymal tumor with gastroblastoma-like features harboring PTCH1::GLI2 fusion. Virchows Arch. 2024;485(3):563-567. 3. Shibayama T, et al. Ovarian Sex Cord Tumor Harboring FUS::CREM Fusion: An Ovarian Counterpart of Inflammatory and Nested Testicular Sex Cord Tumor? Am J Surg Pathol. 2024;48(6):773-775. 4. Shibayama T, et al. Pulmonary inflammatory leiomyosarcoma represents a potential diagnostic pitfall of DNA methylation-based classification of sarcomas: a case report. BMC Pulm Med. 2023 Sep 4;23(1):324. 5. Shibayama T, et al. Cytokeratin-positive Malignant Tumor in the Abdomen With EWSR1/FUS-CREB Fusion: A Clinicopathologic Study of 8 Cases. Am J Surg Pathol. 2022 Jan 1;46(1):134-146. 6. Shibayama T, et al. Clinicopathologic Characterization of Epithelioid Hemangioendothelioma in a Series of 62 Cases: A Proposal of Risk Stratification and Identification of a Synaptophysin-positive Aggressive Subset. Am J Surg Pathol. 2021 May 1;45(5):616-626. 7. Shibayama T, et al. Screening of BCOR-CCNB3 sarcoma using immunohistochemistry for CCNB3: A clinicopathological report of three pediatric cases. Pathol Int. 2015 Aug;65(8):410-4. |
| 所属学会 |
日本病理学会 日本臨床細胞学会 |